美国静脉论坛C2疾病研究 Retreat 确认静脉曲张生物学与差异为优先研究方向
美国静脉论坛研究委员会为确定C2疾病的高产出研究主题举办了研究优先事项Retreat,采用简短报告、开放小组讨论和强制排序调查。结果显示,理解病因与生物学机制、寻找新药物疗法以及实现医疗公平是最高研究优先级。
要点
- C2疾病研究优先事项包括病因与生物学机制、新药物疗法及医疗公平。
- 多学科团队通过 retreat 前后强制排序调查确定研究优先级。
- 该文件可为未来C2静脉曲张研究提供方向指导。
核心结论
- C2疾病最高研究优先级为理解病因与生物学机制、识别新药物疗法,其次是实现医疗公平。
研究设计与样本
- 美国静脉论坛研究委员会举办虚拟研究优先事项Retreat,对委员会成员、演讲者和讨论者(n=12)在会前和会后进行强制排序调查。
主要发现
- 会前和会后排序均由来自血管外科、介入放射学、血管医学和静脉学的多学科团队完成。
- 理解病因与生物学机制、识别新药物疗法被评为最高研究优先级,其次是实现C2患者医疗公平。
临床怎么用
- 研究结果可为研究者开展C2静脉曲张疾病研究提供方向指导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Funding for research in varicose vein disease has traditionally been poor, despite its negative impact and high prevalence, affecting millions of people. To identify high-yield topics that would benefit from dedicated research and funding, the American Venous Forum (AVF) Research Committee hosted a Research Priorities Retreat for C2 disease. We hypothesized that an open forum of brief presentations, open panel discussions, and forced rank surveys would identify scientific priorities in C2 disease and provide a foundation for designing future research efforts. METHODS: The initial list of topics for discussion and potential speakers was reviewed by members of the 2024 AVF Research Committee based on recently published guidelines on C2 disease and on scientific experience. All participants were required to participate synchronously during the virtual event. The format prioritized high-yield topics, opportunities for robust discussion, and transparency for registered AVF members. A force rank survey was administered before and after the retreat to committee members, panel speakers, and discussions. In addition, registrants who attended were also given the opportunity to rank topics after discussion. RESULTS: The speakers, discussants, and committee members (n = 12) who ranked topics immediately before and after the retreat represented a multidisciplinary team from vascular surgery, interventional radiology, vascular medicine, and phlebology, with clinical and scientific doctorate experience. Understanding the underlying etiologies and the biological mechanisms and identifying new medical therapies were considered the highest research priorities, followed by ways to achieve health care equity for patients with C2 disease. CONCLUSIONS: This study represents a multidisciplinary effort by the AVF Research Committee to identify research priorities in C2 disease. The retreat was carefully planned and transparently executed, providing a mechanism to inform future research efforts of the AVF. Future biologic therapies to target and improve the treatment of varicose veins and health care equity were the top priorities in post event ranking. The resulting document may provide guidance for investigators hoping to pursue research in C2 varicose vein disease.
引用
- Sachdev-Ost U, Obi A, Fukaya E, et al. Results of the American Venous Forum research retreat on C2 disease confirms that the biology of varicose veins including etiology, progression, and novel therapeutics, as well as disparities, are top research priorities. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41802538. doi:10.1016/j.jvsv.2026.102463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。